Gilead Sciences News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

02.05.19	Gilead Sciences Inc. Q1 adjusted earnings Beat Estimates (RTTNews)
16.04.19	Gilead Sciences Enters Strategic Collaboration With Insitro - Quick Facts (RTTNews)
29.03.19	ARDS On The Move, GLPG Reports Positive Data, PRTO Plunges On PATENCY-2 Results (RTTNews)
06.03.19	BIOL On Watch, CELG Faces FDA In Sep., Scott Gottlieb Resigns (RTTNews)
14.02.19	Court Rules HIV Drug Personal Injury Cases May Proceed Against Gilead Sciences (RTTNews)
12.02.19	NASH Drugs At A Crossroads... (RTTNews)
11.02.19	Gilead Sciences Late-Stage Study Of Selonsertib Fails To Meet Primary Endpoint (RTTNews)
04.02.19	Gilead Sciences Inc. Q4 adjusted earnings Miss Estimates (RTTNews)
20.01.19	Trial & Error: The Changing Landscape Of Cancer (RTTNews)
08.01.19	Japan Okays Approves Gilead Sciences' Epclusa (RTTNews)
20.12.18	Agenus Collaborates With Gilead On Immuno-Oncology Therapies; Stock Surges (RTTNews)
19.12.18	Gilead Sciences, Scholar Collaborate On Novel Therapies For Fibrotic Diseases (RTTNews)
10.12.18	Gilead Sciences Appoints Roche Executive Daniel O'Day As Chairman And CEO (RTTNews)
10.12.18	WSJ : Gilead Sciences Plans To Appoint Roche Executive Daniel O'Day As CEO (RTTNews)
04.12.18	Gilead Sciences : China Approves Descovy For Treatment Of HIV-1 Infection (RTTNews)
19.11.18	Gilead Sciences: China NMPA Approves Vemlidy For Chronic HBV Infection (RTTNews)
25.10.18	Gilead Sciences Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
03.10.18	Gilead Sciences Announces 96-Week Results From Phase 3 Study Of Biktarvy (RTTNews)
03.10.18	Gilead Sciences Reports Approval Of Biktarvy In Hong Kong - Quick Facts (RTTNews)
25.09.18	Gilead To Offer Generic Versions Of Hepatitis C Treatments Epclusa, Harvoni (RTTNews)
12.09.18	FOMX Soars On Acne Trial Data, GLPG Abuzz, ACRX To Face FDA Panel In Oct. (RTTNews)
06.09.18	Gilead : Phase 2 TORTUGA Study Of Filgotinib Achieves Primary Efficacy Endpoint (RTTNews)
27.08.18	Kite : Yescarta Gets EMA For Treatment Of Relapsed Or Refractory DLBCL And PMBC (RTTNews)
06.08.18	Gilead Sciences: China Administration Approves Genvoya To Treat HIV-1 Infection (RTTNews)
25.07.18	Gilead Sciences CEO John Milligan To Step Down - Quick Facts (RTTNews)
25.07.18	Gilead Sciences Inc. Q2 adjusted earnings of $1.91 per share (RTTNews)
24.07.18	Gilead Reports Data On Impact Of Truvada On New HIV Infections - Quick Facts (RTTNews)
25.06.18	EC Grants Authorization For Gilead's Biktarvy For Treatment Of HIV-1 Infection (RTTNews)
31.05.18	CRSP Falls On Clinical Hold, PFE Gets FDA Nod, ARWR To Report Data In Nov. (RTTNews)
30.05.18	Gilead Sciences Reports Approval Of Epclusa In China - Quick Facts (RTTNews)
15.05.18	Gilead Sciences Says FDA Approves Once-daily Oral Truvada (RTTNews)
01.05.18	Gilead Sciences Inc. Q1 adjusted earnings Miss Estimates (RTTNews)
27.04.18	/R E P R I S E -- Invitation aux médias - Annonce concernant un soutien financier important aux organismes environnementaux régionaux/ (PR Newswire)
27.04.18	Gilead Sciences: CHMP Adopts Positive Opinion For Biktarvy - Quick Facts (RTTNews)
19.04.18	Astellas Announces Sale of Certain Agensys Research Facilities to Kite, a Gilead Company (PR Newswire)
03.04.18	Will These Drugs Reach Blockbuster Status? (RTTNews)
14.03.18	Grants Awarded to 13 Canadian Initiatives to Help Advance the Goal of Eliminating Chronic Hepatitis C Infection in High-Risk Populations (PR Newswire)
13.03.18	Québec élargit l'accès des patients aux traitements contre l'hépatite C chronique (PR Newswire)
13.03.18	Quebec Expands Patient Access to Chronic Hepatitis C Therapies (PR Newswire)
05.03.18	New Drugs Approved In February (RTTNews)
28.02.18	Ontario Expands Patient Access to Chronic Hepatitis C Therapies On Public Drug Plan (PR Newswire)
22.02.18	Gilead Unit, Sangamo Therapeutics Enter Worldwide Collaboration (RTTNews)
22.02.18	Kite, a Gilead Company, And Sangamo Therapeutics Announce Collaboration To Develop Next-Generation Engineered Cell Therapies For The Treatment Of Cancer (PR Newswire)
08.02.18	ViiV Files Patent Infringement Lawsuit Against Gilead Sciences On Bictegravir (RTTNews)
07.02.18	GILD's Sales Wane, SGMO Safe With CHAMPIONS, All's Not Well With Veterinarians? (RTTNews)
06.02.18	Gilead Sciences Inc. Q4 Profit Retreats (RTTNews)
26.01.18	Biotech Stocks Facing FDA Decision In February (RTTNews)
22.01.18	Big Banks and Customer Experience: Can Banks Avoid the Same Fate as Retailers like Sears? (PR Newswire)
16.01.18	The Race To Find A Treatment For NASH (RTTNews)
12.12.17	Réouverture du service de radiologie à Plessisville (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Zurich Insur Gr	547.60	3.13 %	K V
Logitech Intl	70.26	2.57 %	K V
Givaudan	3’919.00	1.45 %	K V
ABB	49.58	1.08 %	K V
Swiss Re	127.20	0.99 %	K V
Holcim	89.86	-0.24 %	K V
Sika	229.00	-0.35 %	K V
Swisscom	505.50	-0.49 %	K V
Nestle	75.96	-0.73 %	K V
CieFinRichemont	117.65	-0.80 %	K V

mehr

17:58		Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen
17:58		SLI aktuell: Anleger lassen SLI letztendlich steigen
17:58		SMI aktuell: SMI präsentiert sich letztendlich fester
17:56		Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an
16:17		Roche-Aktie stabil: Swissmedic genehmigt subkutane Version von Ocrevus
15:58		Pluszeichen in Zürich: SLI auf grünem Terrain
15:58		Schwache Performance in Zürich: SPI notiert nachmittags im Minus

17:58

Gute Stimmung in Zürich: Anleger lassen SPI schlussendlich steigen

17:58

SLI aktuell: Anleger lassen SLI letztendlich steigen

17:58

SMI aktuell: SMI präsentiert sich letztendlich fester

17:56

Novartis-Aktie fester: Novartis passt Umsatzziele nach oben an

16:17

Roche-Aktie stabil: Swissmedic genehmigt subkutane Version von Ocrevus

15:58

Pluszeichen in Zürich: SLI auf grünem Terrain